Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 3
1975 5
1976 12
1977 13
1978 9
1979 26
1980 18
1981 11
1982 17
1983 32
1984 29
1985 19
1986 50
1987 34
1988 28
1989 29
1990 28
1991 20
1992 38
1993 32
1994 24
1995 34
1996 22
1997 20
1998 31
1999 30
2000 21
2001 24
2002 21
2003 24
2004 14
2005 23
2006 22
2007 18
2008 21
2009 14
2010 16
2011 12
2012 15
2013 17
2014 17
2015 10
2016 13
2017 8
2018 15
2019 8
2020 4
2021 2
2022 4
2023 2
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

932 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of salbutamol and ipratropium bromide in the management of acute bronchiolitis--a clinical trial.
Karadag B, Ceran O, Guven G, Dursun E, Ipek IO, Karakoc F, Ersu RH, Bozaykut A, Inan S, Dagli E. Karadag B, et al. Respiration. 2008;76(3):283-7. doi: 10.1159/000111817. Epub 2007 Nov 28. Respiration. 2008. PMID: 18042975 Clinical Trial.
OBJECTIVES: To investigate the efficacy of ipratropium bromide and salbutamol in the treatment of patients with moderate-severe bronchiolitis. ...Patients were randomly assigned to receive nebulized salbutamol, ipratropium bromide or placebo. Main outcome measures w …
OBJECTIVES: To investigate the efficacy of ipratropium bromide and salbutamol in the treatment of patients with moderate-severe bronc …
Nebulized Ipratropium bromide protects against tracheal and bronchial secretion during bronchoscopy: A randomized controlled trial.
Wang F, Zheng H, Zhang Y, Zhu H, Shi J, Luo Y, Zhang X, Mao H, Herth FJF, Luo F. Wang F, et al. Medicine (Baltimore). 2019 Nov;98(47):e17942. doi: 10.1097/MD.0000000000017942. Medicine (Baltimore). 2019. PMID: 31764793 Free PMC article. Clinical Trial.
METHODS: Patients were randomized 1:1 to receive nebulized 4 ml ipratropium bromide (1 mg, n = 125) or placebo (n = 125) for 15 minutes as premedication, 20 to 40 minutes before bronchoscopy. ...We suggest that routine nebulized ipratropium bromide premedication for …
METHODS: Patients were randomized 1:1 to receive nebulized 4 ml ipratropium bromide (1 mg, n = 125) or placebo (n = 125) for 15 minut …
Randomized controlled trial of ipratropium bromide and salbutamol versus salbutamol alone in children with acute exacerbation of asthma.
Chakraborti A, Lodha R, Pandey RM, Kabra SK. Chakraborti A, et al. Indian J Pediatr. 2006 Nov;73(11):979-83. doi: 10.1007/BF02758300. Indian J Pediatr. 2006. PMID: 17127777 Clinical Trial.
OBJECTIVE: To evaluate effect of addition of ipratropium to salbutamol delivered by metered dose inhaler and spacer in the beginning of treatment of mild to moderate exacerbation of asthma. ...Children getting combination of salbutamol and ipratropium showed signifi …
OBJECTIVE: To evaluate effect of addition of ipratropium to salbutamol delivered by metered dose inhaler and spacer in the beginning …
A randomized, placebo-controlled, double-blind trial on the management of post-infective cough by inhaled ipratropium and salbutamol administered in combination.
Zanasi A, Lecchi M, Del Forno M, Fabbri E, Mastroroberto M, Mazzolini M, Pisani L, Pandolfi P, Nava S, Morselli-Labate AM. Zanasi A, et al. Pulm Pharmacol Ther. 2014 Dec;29(2):224-32. doi: 10.1016/j.pupt.2014.07.008. Epub 2014 Aug 8. Pulm Pharmacol Ther. 2014. PMID: 25111667 Clinical Trial.
Patients were treated for 10 days with either a nebulized combination of salbutamol 1.875 mg/0.5 mL and ipratropium bromide 0.375 mg/0.5 mL, or a placebo, and followed up for another 10 days. Daytime and nighttime cough severity and spirometry testing were assessed before …
Patients were treated for 10 days with either a nebulized combination of salbutamol 1.875 mg/0.5 mL and ipratropium bromide 0.375 mg/ …
A clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis.
Bronsky EA, Druce H, Findlay SR, Hampel FC, Kaiser H, Ratner P, Valentine MD, Wood CC. Bronsky EA, et al. J Allergy Clin Immunol. 1995 May;95(5 Pt 2):1117-22. doi: 10.1016/s0091-6749(95)70215-6. J Allergy Clin Immunol. 1995. PMID: 7751528 Clinical Trial.
The purpose of the present trial was to study the safety and efficacy of a new isotonic aqueous ipratropium bromide nasal spray pump, specifically in patients with perennial nonallergic rhinitis. Two hundred thirty-three patients participated in an 8-week double-blind para …
The purpose of the present trial was to study the safety and efficacy of a new isotonic aqueous ipratropium bromide nasal spray pump, …
Lung Health Study.
Anthonisen NR. Anthonisen NR. Am Rev Respir Dis. 1989 Oct;140(4):871-2. doi: 10.1164/ajrccm/140.4.871. Am Rev Respir Dis. 1989. PMID: 2529803 Clinical Trial. No abstract available.
A comparison of inhaled ipratropium, oral theophylline plus inhaled beta-agonist, and the combination of all three in patients with COPD.
Karpel JP, Kotch A, Zinny M, Pesin J, Alleyne W. Karpel JP, et al. Chest. 1994 Apr;105(4):1089-94. doi: 10.1378/chest.105.4.1089. Chest. 1994. PMID: 8162730 Clinical Trial.
To evaluate the role of inhaled ipratropium bromide alone vs oral theophylline plus inhaled beta-agonist or the combination of all three in patients with stable COPD, the following double-blind, placebo-controlled study was conducted. ...However, theophylline and albuterol …
To evaluate the role of inhaled ipratropium bromide alone vs oral theophylline plus inhaled beta-agonist or the combination of all th …
Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation.
Goggin N, Macarthur C, Parkin PC. Goggin N, et al. Arch Pediatr Adolesc Med. 2001 Dec;155(12):1329-34. doi: 10.1001/archpedi.155.12.1329. Arch Pediatr Adolesc Med. 2001. PMID: 11732951 Clinical Trial.
INTERVENTION: Children were randomized to receive either nebulized ipratropium bromide, 250 microg, or nebulized isotonic sodium chloride solution, 1 mL. All children received albuterol and systemic corticosteroids. ...CONCLUSION: The addition of nebulized ipratropium …
INTERVENTION: Children were randomized to receive either nebulized ipratropium bromide, 250 microg, or nebulized isotonic sodium chlo …
Effectiveness and safety of intranasal ipratropium bromide in common colds. A randomized, double-blind, placebo-controlled trial.
Hayden FG, Diamond L, Wood PB, Korts DC, Wecker MT. Hayden FG, et al. Ann Intern Med. 1996 Jul 15;125(2):89-97. doi: 10.7326/0003-4819-125-2-199607150-00002. Ann Intern Med. 1996. PMID: 8678385 Clinical Trial.
Ipratropium was generally well tolerated but was associated with higher rates of blood-tinged mucus (16.8% in the ipratropium group compared with 3.6% in the control group; P = 0.01) and nasal dryness (11.7% in the ipratropium group compared with 3.6% in the …
Ipratropium was generally well tolerated but was associated with higher rates of blood-tinged mucus (16.8% in the ipratropium …
Randomized pilot trial of ipratropium versus placebo in children with critical asthma.
Murphy K, Mahmood N, Craven D, Gallagher J, Ross K, Speicher R, Rotta AT, Shein SL. Murphy K, et al. Pediatr Pulmonol. 2020 Dec;55(12):3287-3292. doi: 10.1002/ppul.25115. Epub 2020 Oct 21. Pediatr Pulmonol. 2020. PMID: 33049119 Clinical Trial.
OBJECTIVE: To test the effects of inhaled ipratropium on clinical outcomes of critical asthma in the first randomized trial of this adjunctive therapy in critically ill children. ...A larger, multicenter trial is warranted to confirm that ipratropium does not improv …
OBJECTIVE: To test the effects of inhaled ipratropium on clinical outcomes of critical asthma in the first randomized trial of this a …
932 results